- Meet Consumers/Patients
|In the News|
Omegaven and Other Alternative Lipids for Treating Liver Disease
Hau D. Le, MD (2010)
Other recent research in this area:
Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome [a retrospective review of four infants who received EN fish oil] Rollins MD, Scaife ER, Jackson WD, Meyers RL, Mulroy CW, Book LS.
Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease [a summary of current data, published in 2010] Koletzko B, Goulet O. SourceDivision of Metabolic and Nutritional Medicine, Dr von Hauner Children’s Hospital, University of Munich Medical Center, Munich, Germany. Curr Opin Clin Nutr Metab Care. 2010 May;13(3):321-6 (Abstract)
Author’s Summary: The observed improvement of PNAC on parenteral lipids with fish oil deserves further exploration. No controlled trials are available, nutritional adequacy and safety of 100% fish oil emulsions are not adequately documented, and currently their use cannot be considered standard care. First data on mixed lipid emulsions with some fish oil are encouraging, and their effects in PNAC should also be explored.
Review and Clinical Update on Parenteral Nutrition–Associated Liver Disease [This article reviews recent literature relating to the pathophysiology and treatment of PNALD] Emma M. Tillman, PharmD University of Tennessee Health Science Center, Memphis, Tennessee (Article)
Updated March 29, 2016